Nasdaq: SIGA/Drug Manufacturers - Specialty & Generic
SIGA Technologies, Inc.
New York, NY, United States
Company overview
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
This profile is for informational purposes only and is not investment advice. Company information may change after the verification date.